Black Patients Less Likely to Receive Therapy

Article

A study in JAMA, the Journal of the American Medical Association, shows that black patients were 30 percent lee likely to receive specialized heart procedures in comparison to white patients.

A study in JAMA, the Journal of the American Medical Association, shows that black patients were 30 percent lee likely to receive specialized heart procedures in comparison to white patients.

Related Videos
What Makes JAK Inhibitors Safe in Dermatology
Potential JAK Inhibitor Combination Regimens in Dermatology
Therapies in Development for Hidradenitis Suppurativa
"Prednisone without Side Effects": The JAK Inhibitor Ceiling in Dermatology
Discussing Changes to Atopic Dermatitis Guidelines, with Robert Sidbury, MD, MPH
How Will Upadacitinib, Povorcitinib Benefit Hidradenitis Suppurativa?
The JAK Inhibitor Safety Conversation
Jonathan Silverberg, MD, PhD, MPH | Credit: George Washington University
Secukinumab and Bimekizumab for Hidradenitis Suppurativa
© 2024 MJH Life Sciences

All rights reserved.